scholarly journals Intravitreal Ziv-Aflibercept in Treatment of Naïve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane

2017 ◽  
Vol 2017 ◽  
pp. 1-5
Author(s):  
Nishant Radke ◽  
Charudutt Kalamkar ◽  
Amrita Mukherjee ◽  
Snehal Radke

Purpose. To study the effect and outcome of intravitreal Ziv-Aflibercept (IVZ) in treatment of Chronic Central Serous Chorioretinopathy (CSCR) related Choroidal Neovascular Membrane (CNVM). Methods. A case report of 48-year-old male patient treated with 1.25 mg/0.05 ml IVZ (total 3 doses at monthly intervals) in CSCR related CNVM. Pre- and posttreatment fundus fluorescein angiography (FFA) and Optical Coherence Tomography (OCT) were done to document response along with improvement in visual acuity. Patients. Single eye of a 48-year-old male patient. Results. Regression of CNVM was noted with improvement of macular contour and thickness on OCT and cessation of leakage on FFA. Visual acuity improved from 3/60, <N36 to 6/12, N12. Discussion. Anti-VEGF injections have shown benefit in treatment of CNVM. There is very little information about benefit of IVZ in CSCR related CNVM. Conclusion. IVZ is effective in regression of CSCR related CNVM and is associated with better macular anatomy and improved visual function.

2018 ◽  
Vol 10 ◽  
pp. 251584141880713 ◽  
Author(s):  
Ramesh Venkatesh ◽  
Manisha Agarwal ◽  
Meha Kantha

Objective: To evaluate the role of oral rifampicin in the management of chronic central serous chorioretinopathy. Methods: Retrospective analysis of patients diagnosed with chronic central serous chorioretinopathy (duration >3 months) and treated with oral rifampicin 600 mg daily for a maximum period of 3 months was carried out. Baseline visual acuity, fundus fluorescein angiography, and optical coherence tomography were recorded and the patients were followed up. Resolution of subretinal fluid and improvement in visual acuity were the main outcome measures. Recurrence of subretinal fluid was noted. Any adverse reaction to the drug was monitored. Results: Nine eyes of eight patients were included in the study. The average age of the patients was 41.90 years (range 32–52 years). Mean duration of symptoms was 16 months (range 3–60 months). Mean duration of follow-up was 10.11 months (range 3–33 months). Fluorescein angiography showed four eyes with subfoveal leaks and five eyes with diffuse retinal pigment epitheliopathy. Complete resolution of subretinal fluid was achieved in four of the nine eyes – two patients at the end of 1 month, one patient each at the end of 2 and 3 months, respectively. Visual acuity improvement was noted in four of the nine eyes. Three patients had one-line improvement and one patient had a two-line visual improvement. None of the patients had severe adverse events for which the drug had to be discontinued. None of the patients had recurrence of subretinal fluid after the discontinuation of the drug. Conclusion: Oral rifampicin could provide a useful, effective, and cost-effective alternative for treatment of patients with chronic central serous choroidopathy and evidence of healthier retinal pigment epithelium, those with focal leakage. It was not effective in eyes with diffuse retinal pigment epitheliopathy.


Author(s):  
Saeed Karimi ◽  
Amir Arabi ◽  
Toktam Shahraki ◽  
Sare Safi

Purpose: To present a case of central serous chorioretinopathy (CSC) in association with regressed familial retinoblastoma. Case Report: A 23-year-old man with regressed unilateral familial retinoblastoma in his left eye presented with decreased vision of the left eye since two months ago. The patient had undergone chemotherapy and cryotherapy for the treatment of retinoblastoma 20 years ago. In the left eye, funduscopy disclosed regressed mass of retinoblastoma, inferonasal to the optic disc, and focal subfoveal neurosensory detachment. Optical coherence tomography (OCT) and fluorescein angiography revealed CSC. As there was no sign of recurrence of retinoblastoma and retinal findings did not show late-onset chemotherapy-related retinopathy, the patient was diagnosed with CSC and followed up. After two months, visual acuity of the left eye improved, and repeated macular OCT revealed absorption of the subretinal fluid. Conclusion: Subretinal fluid accumulation in a patient with regressed retinoblastoma is not always a sign of tumor recurrence or a treatment-related retinopathy.


QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
M E B Samaan ◽  
A H Saad ◽  
T H Mohammed ◽  
Y A Elzankalony

Abstract Background Behçet disease is an obliterative and necrotizing systemic vasculitis that involves different organ systems. It affects both arteries and veins, mainly the veins. Ocular affection is one of the major criteria of Behçet disease; the most common ocular presentation is bilateral non-granulomatous panuveitis with retinal vasculitis. Purpose To identify early, evaluate and follow-up properly the posterior segment involvement in Behçet disease cases with the help of Fundus fluorescein angiography and Optical coherence tomography. Patients and Methods This is a descriptive cross sectional study involved 40 eyes. All patients had a complete ophthalmological examination, a comprehensive history taking as well as review of systems and the laboratory tests. This is followed by pupillary dilatation and retinal imaging by fundus fluorescein angiography and optical coherence tomography. Results On ophthalmological examination, 35 eyes had retinal affection due to Behçet disease and 5 eyes are retina-free. The most common retinal affection was vasculitis in 29 eyes, followed by optic nerve affection in 10 eyes then less common was retinitis in 6 eyes. Regarding visual acuity (VA) 14 eyes had low visual acuity of less than (6/60), 21 eyes had VA between (6/60 – 6/12) and 5 eyes had good visual acuity of more than (6/12). Fluorescein angiograms showed that, 36 eyes representing 90% of the total eyes had abnormal angiogram; vascular leakage was the commonest abnormality in 29 eyes, less common was optic disc edema in 12 eyes, then retinitis in 6 eyes. Macular edema was present in the angiogram of 6 eyes. About OCT, there were abnormalities in 33 eyes; macular edema was the most common in 21 eyes, epiretinal membrane (ERM) in 9 eyes, then neurosensory detachment (NSD) and macular hole each was seen in 4 eyes. Conclusion This study demonstrated that posterior pole involvement, retinal vascular leakage, optic disc hyperfluorescence, and macular leakage are significantly associated with worse VA in Behçet retinal vasculitis. This suggests that, use of Fundus Fluorescein Angiography and Optical Coherence Tomography in evaluation of Behçet retinal vasculitis is clinically significant in predicting visual prognosis and determining of treatment efficacy.


2020 ◽  
Vol 15 (02) ◽  
pp. 122-133
Author(s):  
Rainer Guthoff

AbstractThe frequency of diabetic retinopathy increases and is a leading cause of blindness in the working population. Recommended exams are testing of the visual acuity, ophthalmoscopy with dilated pupils, fundus fluorescein angiography and optical coherence tomography (OCT). By OCT the diagnosis and monitoring of diabetic macular edema has vastly improved. By intravitreal medications such as intravitreal anti-VEGF or intravitreal steroids macular edema can be treated successfully. Panretinal laser photocoagulation is the gold-standard in the therapy of proliferative diabetic retinopathy. Patients benefit from good co-working of general practitioner and ophthalmologist concerning screening and treatment.


2019 ◽  
Vol 100 (4) ◽  
pp. 601-605
Author(s):  
A N Samoylov ◽  
A N Korobitsin

Aim. Develop a methodology and evaluate the clinical results of laser treatment of patients with chronic central serous chorioretinopathy in the presence of a leakage point in the foveola zone. Methods. The results of patients (32 eyes) with central serous chorioretinopathy after laser exposure in the avascular area were analyzed. The best-corrected visual acuity in these patients before treatment was 0.7 to 1.0 (average 0.78±0.15) with a height of neuroepithelial detachment of 162 to 328 μm according to optical coherence tomography. No signs of choroidal neovascularization was detected in angio mode on optical coherence tomography. The treatment was performed with an Ellex Integre Pro Scan 561 nm. The follow-up examination was performed in 1 and 6 months. Results. In 1 month, positive dynamics of both functional and anatomical parameters was noted in all eyes. According to the optical coherence tomography, a complete attachment of the neuroepithelium in the central zone of the retina occurred, detachment of the neuroepithelium was absent. Best-corrected visual acuity in 1 month after treatment increased to 0.89±0.08, in 6 months to 0.92±0.04. The study revealed a correlation between visual acuity and the central thickness of the retina in the fovea, there were no complaints about the appearance of scotomas after laser treatment in the foveola zone. Conclusion. The developed techniqe of laser exposure on the foveola zone in case of chronic central serous chorioretinopathy with a 561 nm laser demonstrated high clinical efficacy and safety and can be recommended to all patients with central serous chorioretinopathy.


2021 ◽  
Vol 9 (1) ◽  
pp. 62
Author(s):  
Andi Arus Victor

Central serous chorioretinopathy (CSC) is one of the leading causes of blindness in middle-aged population. This case report describes case of CSC associated with amlodipine consumption. A 62-years old woman came with blurry vision on the right eye (RE) for 25 days, prior to admission. Patient was hypertensive and on routine calcium channel blocker (CCB, amlodipine) for the last two months. Initial best corrected visual acuity (BCVA) was 0.3 for her RE and 0.8 on her left eye (0.8). Anterior segment examinations of both eyes were within normal limits. Funduscopy revealed serous retinal detachment on the macula of RE. Optical coherence tomography (OCT) of RE showed subretinal and below choroid fluid accumulation and central macular thickness of 352 µm. Patient was treated with non-steroidal anti-inflammatory drug (NSAID) and vitamins but the complaint worsened. Amlodipine was ceased on the third month of treatment. CSC resolved and final BCVA was 1.0. There might be an association between CCB consumption to incidence of CSC. Our study was the first to describe such occurrence. Further study is required to confirm this association Keywords: Central serous chorioretinopathy, calcium channel blocker, amlodipine, calcium ion, pathogenesis.   Korioretinopati Serosa Sentral Terkait Penggunaan Penghambat Kanal Kalsium: Sebuah Laporan Kasus Abstrak Central serous chorioretinopathy (CSC) merupakan salah satu penyebab utama kebutaan pada populasi usia paruh baya. Laporan kasus ini mendeskripsikan sebuah kasus CSC yang berkaitan dengan konsumsi Amlodipine. Seorang wanita berusia 62 tahun datang dengan keluhan pandangan buram pada mata kanan sejak 25 hari sebelum datang ke Rumah Sakit. Pasien didiagnosis dengan hipertensi dan rutin mengkonsumsi calcium channel blocker (CCB, amlodipine) dalam 2 bulan terakhir. Pemeriksaan tajam visual terbaik / best corrected visual acuity (BCVA) di awal menunjukkan hasil 0.3 pada mata kanan dan 0.8 pada mata kiri. Pemeriksaan anterior segmen pada kedua mata dalam batas normal. Pemeriksaan funduskopi menunjukan ablasio retina serosa pada makula mata kanan. Pemeriksaan optical coherence tomography (OCT) pada mata kanan menunjukkan hasil akumulasi cairan pada subretina dan dibawah koroid, serta ketebalan makula sentral yaitu 352µm. Pasien diberikan tatalaksana berupa non-steroidal anti-inflammatory drug (NSAID) dan vitamin, namun keluhan dirasa memburuk. Konsumsi amlodipine dihentikan pada bulan ke 3. CSC dinyatakan sembuh dengan BCVA akhir 1.0. Terdapat kemungkinan hubungan antara konsumsi CCB dengan insidensi CSC. Studi kami merupakan studi pertama yang mendeskripsikan kejadian tersebut. Dibutuhkan studi lebih lanjut untuk mengkonfirmasi hubungan tersebut. Kata kunci: Korioretinopati serosa sentral, penghambat kanal kalsium, amlodipine, ion kalsium, patogenesis


2019 ◽  
Vol 2 ◽  
pp. 1 ◽  
Author(s):  
Anibal Martin Folgar ◽  
Jorge Oscar Zarate

We present a 57-year-old referred reduced visual acuity who was in treatment with paclitaxel for developing metastatic breast adenocarcinoma. Ophthalmoscopic examination, optical coherence tomography, and autofluorescence show the cystoid macular edema, but fluorescein angiography is normal, without leakage of dye in the late times. The patient responds well 8 weeks after stopping antineoplastic. Paclitaxel can cause cystoid macular edema and lifting a recovery both anatomical and functional of the macula.


Sign in / Sign up

Export Citation Format

Share Document